Fairvalue-Calculator Fairvalue-Calculator
EN DE

Cibus, Inc (CBUS) Fair Value & Analysis

Healthcare · US · Market cap $110M

Price$1.37
Fair Value$1.29
Upside-5.8%
Quality95/100
Evidence: Low Range $0.9700 – $1.61

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Cibus, Inc (CBUS) currently trades at $1.37, while our model-based Fair Value estimate is $1.29 — implying the stock looks roughly 5.8% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -32% Regeneron Pharmaceuticals, Inc (REGN) -4% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +1% Alnylam Pharmaceuticals, Inc (ALNY) -82%

Frequently asked questions

Is Cibus, Inc (CBUS) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $1.29 versus a price of $1.37 — about −6% (overvalued). Model-based estimate, not financial advice.
What is the fair value of CBUS?
Our 21-model fair value for Cibus, Inc is $1.29 (as of Jun 24, 2026), built from audited fundamentals. The current price is $1.37.
What is the quality score of CBUS?
Cibus, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.